CEU

ORG Health Care / Pharmaceuticals Momentum 9.3 NORMAL Primary: Spectral Shift

CEU develops or commercializes radiopharmaceutical cancer therapies. Appears in healthcare M&A coverage alongside pharmaceutical consolidation trends in precision oncology.

Active in radiopharmaceuticals sector amid consolidation; referenced in context of Chiesi-KalVista ($1.9B) and Santhera earnings activity

0.11

PSI Score

9.3

Momentum

Confidence

Connections

Connected Entities

San Francisco

Watch This Entity

PSI Intelligence

30-Day Trend

Signal Decomposition

Attention Cascade

-0.000

Narrative Drift

0.000

Spectral Shift

420.548

Sentiment-Momentum Divergence

0.000

Source Concentration

1.000

Network Analysis

1 Degree Centrality

Centrality History

Entity	Weight	Status	First Seen
San Francisco	49	NEW

Article Coverage (0)

Date	Lane	Title

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-05-07 ← Intelligence Network